Health Plan Business

From Health Plan Weekly - Kaiser Family Foundation’s new study shows that opioid addiction and overdose treatments cost large U.S. employers $2.6 billion in 2016. Two major business coalitions focused on health care tell AIS Health that the crisis affects everyone, but assert that employers are focused more on such matters as plan benefit design changes for opioid alternatives and working with health plan and PBM partners on services — and less on costs. Read more

From Health Plan Weekly - Industry experts say CMS took an important step to cover diagnostic laboratory tests using Next Generation Sequencing (NGS) for patients with advanced cancer, yet they disagree about whether insurers will follow that lead. CMS made the move after the FDA’s approval of the FoundationOne CDx (F1CDx) test, which CMS describes as the first “NGS-based in vitro diagnostic test that is a companion diagnostic for 15 targeted therapies.” The test can detect… Read more

It's quick and easy to sign up for FREE access to!

Why do I need to register?

Resources for Paid Subscribers
Not a Paid Subscriber?

Check out all of the benefits, sample issues & more!